Drugs that contain Alprostadil
1. Caverject patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5741523 | PFIZER | Stabilized prostaglandin E1 |
Apr, 2015
(9 years ago) | |
Market Authorisation Date: 27 June, 1996
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CAVERJECT family patents
2. Caverject Impulse patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5501673 | PFIZER | Injection cartridge |
Apr, 2013
(11 years ago) | |
| US5716338 | PFIZER | Dual-chamber type injection cartridge with bypass connection |
Feb, 2015
(9 years ago) | |
Market Authorisation Date: 11 June, 2002
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CAVERJECT IMPULSE family patents
3. Muse patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5474535 | MYLAN SPECIALITY LP | Dosage and inserter for treatment of erectile dysfunction |
Dec, 2012
(11 years ago) | |
| US5886039 | MYLAN SPECIALITY LP | Method and composition for treating erectile dysfunction |
Mar, 2016
(8 years ago) | |
Market Authorisation Date: 19 November, 1996
Treatment: Treatment of erectile dysfunction
Dosage: SUPPOSITORY;URETHRAL
More Information on Dosage
MUSE family patents